Bioneer Corporation
064550.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$200.29B
Close$
Share Statistics
| Market cap | $200.29 Billion |
|---|---|
| Enterprise Value | $243.92 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-108.99 |
| Beta | 0.33 |
| Outstanding Shares | 25,810,291 |
Return
| Return on Equity | -8.39% |
|---|---|
| Return on Assets | -4.78% |
| Return on Invested Capital | 36.20% |
Valuation & Multiples
| P/E Ratio | -10.91 |
|---|---|
| PEG | 17.17 |
| Price to Sales | 0.67 |
| Price to Book Ratio | 0.87 |
| Enterprise Value to Revenue | 0.82 |
| Enterprise Value to EBIT | 2.21 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$52.60 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bioneer Corporation
608 employees
CEO: Han-Oh Park Bioneer Corporation, established in 1992 and headquartered in Daejeon, South Korea, is a biotechnology company involved in diverse fields such as research products, molecular diagnostics, pharmaceuticals, and probiotics. For the biotechn...